32 min listen
What Do You Do When You Don't Have Enough Trial Locations? with Krystyna Kowalczyk
What Do You Do When You Don't Have Enough Trial Locations? with Krystyna Kowalczyk
ratings:
Length:
30 minutes
Released:
Mar 18, 2021
Format:
Podcast episode
Description
Topics covered and questions you’ll uncover during this episode:The three tenets of OncoBay’s approach to cutting-edge cancer researchHow to prepare staff for the complexities of a 21st-century oncology trialWhy we need to evolve from serial to real-time data assessment OncoBay’s “just-in-time” enrollment model (and a touching success story)Why investing up-front in site preparedness is critical to maximizing impact in researchHow the just-in-time model can help address diversity challenges in enrollmentWhy new technologies and methodologies often create discomfort, and what leaders can do about itHow you can make 1 + 1 equal 3 when you combine tools effectivelyWhy putting together the right team is both more challenging and more critical than putting together the technologyWhat Krystyna looks for when assessing potential team members Why she’s excited for the next generation of industry employeesResources mentioned within the episode:https://www.oncobay.comhttps://www.linkedin.com/company/oncobay-clinical/https://www.facebook.com/oncobayclinicalhttps://twitter.com/OncoBayConversations in Clinical Trial Readiness Interview SeriesArcheMedX
Released:
Mar 18, 2021
Format:
Podcast episode
Titles in the series (12)
Demystifying Decentralized Clinical Trials with R'Kes Starling: R’Kes Starling talks with Kelly Ritch, EVP of Product and Clinical Research Solutions at ArcheMedX, about how decentralized clinical trials (DCTs) can expand access to clinical trials and promote patient participation. He shares the personal experiences that motivated him to found Reveles, recounts a poignant story of a patient who was empowered and given hope through DCT, and describes how he and his company are working to overcome the hurdles on the path to DCT. Anyone wondering whether DCT is right for them will appreciate R’Kes’s take, which unites his personal and professional experiences in a perspective that is both empathetic and firmly grounded in reality. by Conversations in Clinical Trial Readiness